Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke

Fig. 2

Potential targets of MSC-mediated immunomodulation. MSCs, mesenchymal stem cells; IL, interleukin; IDO, indoleamine 2,3-dioxygenase; SOD, superoxide dismutase; STAT, signal transducer and activator of transcription; PGE2, prostaglandin E2; sHLA-G5, soluble human leukocyte antigen-G5; TGF-β, transforming growth factor-β; CD, cluster of differentiation; TSG-6, tumor necrosis factor-α-stimulated gene-6; NO, nitric oxide; Fas, TNF receptor superfamily, member 6; C3, Complement 3; CXCR, C-X-C chemokine receptor; NK cells, natural killer cell; DCs, dendritic cells

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512